Ventricular Septal Defect Clinical Trial
Official title:
A Multi-center, Single Arm, Real-World Registry Assessing the Clinical Use of the Cera™ VSD Occluder
The objective of this post-market registry is to assess the safety and performance of the Lifetech Cera™ VSD occluder in a real-world and on-label fashion.
The study intends to collect data from patients who have implanted with the device before 2022. The study is expected to completed by the end of 2024. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03684161 -
Cardiopulmonary Function in Adults Born With a Ventricular Septal Defect
|
||
| Completed |
NCT01120964 -
Intravenous L-Citrulline to Treat Children Undergoing Heart Bypass Surgery : Revised Protocol
|
Phase 1/Phase 2 | |
| Completed |
NCT02914652 -
The Cardiopulmonary Effect of Inhaled Beta-2-agonists on Adult Patients Born With Ventricular Septum Defects.
|
Phase 4 | |
| Recruiting |
NCT06298344 -
The Role of Thiamine After Transcatheter Closure in Children With Left-to-Right Shunt Congenital Heart Disease
|
Early Phase 1 | |
| Recruiting |
NCT05688670 -
Regional Anesthesia Following Pediatric Cardiac Surgery
|
Phase 4 | |
| Completed |
NCT02138435 -
Longterm Outcome After Ventricular Septal Defect Closure
|
N/A | |
| Recruiting |
NCT05253209 -
A Study Evaluating the Efficacy and Safety of IV L-Citrulline for the Prevention of Clinical Sequelae of Acute Lung Injury Induced by Cardiopulmonary Bypass in Pediatric Patients Undergoing Surgery for Congenital Heart Defects
|
Phase 3 | |
| Completed |
NCT00556361 -
Use of Ketamine Prior to Cardiopulmonary Bypass in Children
|
Phase 2 | |
| Completed |
NCT05200910 -
The Effect of Transcatheter VSD Closure on Children's Appetite, Hormones and Growth
|
||
| Recruiting |
NCT03127748 -
Cardiac Function After Transcatheter VSD Closure
|
N/A | |
| Enrolling by invitation |
NCT06214182 -
Immune Heterogeneity Before and After Cardiopulmonary Bypass in Children
|
||
| Active, not recruiting |
NCT04667455 -
Improving Care for Children With Congenital Heart Disease.
|
N/A | |
| Completed |
NCT04417712 -
Lifetech KONAR MFO Post-Market Clinical Follow-Up Study
|
||
| Completed |
NCT01313832 -
The Effect of Remote Ischemic Preconditioning on the Ischemic Reperfusion Injury in Infants With Ventricular Septal Defect and Pulmonary Hypertension
|
N/A | |
| Active, not recruiting |
NCT04017975 -
Optical Tissue Identification for Myocardial Architecture
|
Phase 2 | |
| Completed |
NCT01915277 -
A Phase I Study of Dexmedetomidine Bolus and Infusion in Corrective Infant Cardiac Surgery: Safety and Pharmacokinetics
|
Phase 1 | |
| Recruiting |
NCT03941691 -
A Trial to Evaluate the Safety and Efficacy of a Fully Degradable Ventricular Septal Defect (VSD) Closure
|
N/A | |
| Completed |
NCT04859036 -
The Effect of Transcatheter Ventricular Septal Defect Closure on Heart Rate Variability Parameters
|